Provided by Tiger Trade Technology Pte. Ltd.

Allarity Therapeutics Inc

1.04
0.0000
Post-market: 1.060.0200+1.92%17:47 EDT
Volume:28.91K
Turnover:30.33K
Market Cap:16.45M
PE:-1.32
High:1.08
Open:1.06
Low:1.03
Close:1.04
52wk High:1.84
52wk Low:0.7687
Shares:15.82M
Float Shares:15.79M
Volume Ratio:0.21
T/O Rate:0.18%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7895
EPS(LYR):-0.7811
ROE:-157.09%
ROA:-25.31%
PB:4.65
PE(LYR):-1.33

Loading ...

Apr 01, 2022

Major Issues Report

8-K/A [Amend] - Current report
Apr 01, 2022

Major Issues Report

8-K - Current report
Mar 31, 2022

Major Issues Report

8-K - Current report
Jan 20, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 18, 2022

Major Issues Report

8-K - Current report
Jan 06, 2022

Major Issues Report

8-K - Current report
Dec 27, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Dec 22, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Dec 22, 2021

Major Issues Report

8-K - Current report
Dec 22, 2021

Major Issues Report

8-K - Current report
Dec 20, 2021

Major Issues Report

8-K - Current report
Dec 16, 2021

Correspondence

CORRESP [Cover] - Correspondence
Dec 16, 2021

Correspondence

CORRESP [Cover] - Correspondence
Dec 16, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Dec 15, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Dec 10, 2021

Major Issues Report

8-K - Current report
Dec 06, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Nov 23, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 08, 2021

Business Combinations

425 - Prospectuses and communications, business combinations
Nov 08, 2021

Business Combinations

425 - Prospectuses and communications, business combinations